Investor Area

ICU Medical Technologies S.L. has developed KronoSafe System®, a device that allows temporary cardiac pacing with active-fixation leads.

Market Size: 2M procedures/year ⇒ $1B/year
Complication reduction: 35% ⇒ 5%
Time to Market: 8 months



Number of current investors: 6

Contact

ICU MEDICAL TECHNOLOGIES

ICU Medical Technologies S.L. is the Medical Device Company that has developed KronoSafe®. This System allows temporary cardiac pacing with active-fixation leads, adapting for external use the definitive pacemaker generators and electrodes. According to current projections, it will be on sale during 2025.

The increased safety and effectiveness provided by KronoSafe® allows the patient to be discharged from the Intensive Care Unit, freeing up necessary beds for other critical patients. In addition, it provides the safety needed to perform temporary cardiac pacing at home.

The initial investment round will allow us to start sales at the European market, where more than 400,000 procedures per year are done.

Now is the best moment to participate in the KronoSafe® Project.

$1B MARKET

Temporary Cardiac Stimulation is a procedure performed in more than 2M patients every year worldwide.

USERS AND CUSTOMERS

Users: Intensive Care Physicians and Cardiologists in which we will reduce the complications of their patients using KronoSafe®.
Customers: health systems, hospitals; to which we also provide financial savings reducing complications costs and hospital stay.